Annual Report of the Human Medicines Regulations 2012 Advisory Bodies - the Commission on Human Medicines (CHM) and the British Pharmacopoeia Commission
Commission On Human Medicines
Latest Government News
- Record £18 billion a year for Wales in Budget
- Decision: Regulatory approval of Pfizer/BioNTech vaccine for COVID-19
- Secretary of State gives notice of revocation of declaration under Schedule 21 of the Coronavirus Act 2020
- Transparency data: DfT: spend control data for January to March 2021
- Transparency data: DfT: spend control data for April to June 2021
- Guidance: Terms and conditions of student loans
- Guidance: Changes to the delivery of SIA licence-linked training
- Guidance: Teaching SIA licence-linked training courses
- Countryside Stewardship: Facilitation fund
- What happens next?
Thursday, 15 July 2021
Friday, 12 February 2021
Professor Sir Munir Pirmohamed has been appointed by the Secretary of State for Health and Social Care as Chair of the Commission on Human Medicines (CHM).
Monday, 11 January 2021
The Expert Working Group was set up to to identify ways to improve data collection and access to information relevant to research on medicines used during pregnancy and breastfeeding.
Tuesday, 21 July 2020
Annual report of the Human Medicines Regulations 2012 Advisory Bodies - the Commission on Human Medicines (CHM) and the British Pharmacopoeia Commission
Tuesday, 21 July 2020
Annual report of the Human Medicines Regulations 2012 Advisory Bodies - the Commission on Human Medicines (CHM) and the British Pharmacopoeia Commission
Tuesday, 21 July 2020
Annual report of the Human Medicines Regulations 2012 Advisory Bodies - the Commission on Human Medicines (CHM) and the British Pharmacopoeia Commission
Tuesday, 14 April 2020
Expert Working Group concludes there is currently insufficient evidence to establish a link between use of ibuprofen and susceptibility to contracting COVID-19 or the worsening of its symptoms.
Thursday, 21 November 2019
An Expert Working Group (EWG) of the UK’s Commission on Human Medicines (CHM) has published their report on the benefit-risk and risk minimisation measures of the yellow fever vaccine.
Monday, 06 May 2019
Minutes of the meeting and MHRA assessment report
Friday, 19 October 2018
Minutes of the meeting and MHRA assessment report.
Monday, 05 February 2018
An Expert Working Group (EWG) of the UK’s Commission on Human Medicines (CHM) has published their report on the use of hormone pregnancy tests (HPTs) and adverse effects relating to pregnancy including possible birth defects.
Wednesday, 15 November 2017
An Expert Working Group (EWG) of the UK’s Commission on Human Medicines (CHM) has published their report on the use of hormone pregnancy tests (HPTs) and adverse effects relating to pregnancy including possible birth defects.
Wednesday, 15 November 2017
An Expert Working Group (EWG) of the UK’s Commission on Human Medicines (CHM) has published their report on the use of hormone pregnancy tests (HPTs) and adverse effects relating to pregnancy including possible birth defects.
Thursday, 26 March 2015
Seeks views on the role and performance of the Commission on Human Medicines (CHM)
Ministerial Departmental News
- PM's Office, 10 Downing Street
- Cabinet Office
- Department for Business, Innovation and Skills
- Department for Communities and Local Government
- Department for Culture, Media and Sport
- Department for Education
- Department for Environment, Food and Rural Affairs
- Department for International Development
- Department for Transport
- Department for Work and Pensions
- Department of Energy and Climate Change
- Department of Health
- Foreign and Commonwealth Office
- HM Treasury
- Home Office
- Ministry of Defence
- Ministry of Justice
- Northern Ireland Office
- Scotland Office
- Wales Office
- See all departments